These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32781054)

  • 1. Persistent Tunica Vasculosa Lentis as an Independent Risk Factor for Treatment in Retinopathy of Prematurity.
    Patel NA; Fan KC; Al-Khersan H; Yannuzzi NA; Acon D; Rodriguez AJ; Negron CI; Berrocal AM
    Ophthalmol Retina; 2021 Feb; 5(2):217-219. PubMed ID: 32781054
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical persistence of tunica vasculosa lentis.
    Kumar AV; Chhabra MS; Mets MB
    J Pediatr Ophthalmol Strabismus; 2008; 45(4):250-1. PubMed ID: 18705626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic regression of persistent tunica vasculosa lentis associated with retinopathy of prematurity following treatment with intravitreal bevacizumab.
    Goldman DR; Baumal CR
    J Pediatr Ophthalmol Strabismus; 2013 Jun; 50 Online():e27-9. PubMed ID: 24601434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diode laser photocoagulation for threshold retinopathy of prematurity in eyes with tunica vasculosa lentis.
    Seiberth V; Linderkamp O; Vardarli I; Knorz MC; Liesenhoff H
    Am J Ophthalmol; 1995 Jun; 119(6):748-51. PubMed ID: 7785689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic regression of persistent tunica vasculosa lentis associated with retinopathy of prematurity following treatment with intravitreal bevacizumab.
    Goldman DR; Baumal CR
    J Pediatr Ophthalmol Strabismus; 2013 Jun; 50 Online():e27-9. PubMed ID: 23739589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the tunica vasculosa lentis in the rat model of retinopathy of prematurity.
    Favazza TL; Tanimoto N; Munro RJ; Beck SC; Garcia Garrido M; Seide C; Sothilingam V; Hansen RM; Fulton AB; Seeliger MW; Akula JD
    Doc Ophthalmol; 2013 Aug; 127(1):3-11. PubMed ID: 23748796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy of prematurity: clinic and pathogenesis. Disproportion between apoptosis of vitreal and proliferation of retinal vascularization.
    Pau H
    Ophthalmologica; 2008; 222(4):220-4. PubMed ID: 18463422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior Pole Vascular Changes Before Treatment of Retinopathy of Prematurity.
    Prakalapakorn SG; Wallace DK; Freedman SF
    JAMA Ophthalmol; 2017 Dec; 135(12):1430-1433. PubMed ID: 29098279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiography of Florid Tunica Vasculosa Lentis in Persistent Fetal Vasculature.
    Williamson Iii JE; Bas Z; Shields CL
    J Pediatr Ophthalmol Strabismus; 2022; 59(3):204. PubMed ID: 34928764
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis.
    Higashiyama T; Muraki S; Ohji M
    Case Rep Ophthalmol; 2017; 8(1):173-179. PubMed ID: 28611651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of argon and diode photocoagulation combined with supplemental oxygen for the treatment of retinopathy of prematurity.
    Benner JD; Morse LS; Hay A; Landers MB
    Retina; 1993; 13(3):222-9. PubMed ID: 8235104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrolental fibroplasia; animal studies; induced vascular engorgement and hyperplasia of the iris, tunica vasculosa lentis and retina in kittens.
    HEPNER WR
    Pediatrics; 1952 May; 9(5:1):602-6. PubMed ID: 14929616
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent Avascular Retina in Infants With a History of Type 2 Retinopathy of Prematurity: To Treat or Not to Treat?
    Al-Taie R; Simkin SK; Douçet E; Dai S
    J Pediatr Ophthalmol Strabismus; 2019 Jul; 56(4):222-228. PubMed ID: 31322711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis on the pathogenesis of retinopathy of prematurity--it is not VEGF alone but anatomical structures that are crucial.
    Pau H
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):1-3. PubMed ID: 19760429
    [No Abstract]   [Full Text] [Related]  

  • 15. Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity.
    Christiansen SP; Bradford JD
    Am J Ophthalmol; 1995 Feb; 119(2):175-80. PubMed ID: 7832223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Angiographic Abnormalities After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
    Shah N; Gupta MP; Chan RVP
    JAMA Ophthalmol; 2018 Apr; 136(4):436-437. PubMed ID: 29285531
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
    Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D
    Retina; 2011; 31(7):1239-47. PubMed ID: 21555969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prominent tunica vasculosa lentis in a child with retinopathy of prematurity.
    Prenner JL; Capone A; Trese MT
    Retina; 2003 Apr; 23(2):267-8. PubMed ID: 12707619
    [No Abstract]   [Full Text] [Related]  

  • 19. A hybrid form of retinopathy of prematurity.
    Sanghi G; Dogra MR; Dogra M; Katoch D; Gupta A
    Br J Ophthalmol; 2012 Apr; 96(4):519-22. PubMed ID: 22096143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity.
    Toy BC; Schachar IH; Tan GS; Moshfeghi DM
    Ophthalmology; 2016 Oct; 123(10):2166-75. PubMed ID: 27506484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.